Detalles de la búsqueda
1.
Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
AJR Am J Roentgenol
; 217(4): 933-943, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33245680
2.
High Visceral Adipose Tissue Density Correlates With Unfavorable Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
Front Cell Dev Biol
; 9: 710104, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34568324
3.
Random Survival Forests to Predict Disease Control for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Front Mol Biosci
; 8: 618050, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34095216
4.
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib.
Front Mol Biosci
; 8: 624366, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34124139
5.
Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib.
Front Mol Biosci
; 8: 727969, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34527705
6.
Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study.
Cardiovasc Intervent Radiol
; 44(1): 63-72, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32965582
7.
Prognostic Performance of Albumin-Bilirubin Grade With Artificial Intelligence for Hepatocellular Carcinoma Treated With Transarterial Chemoembolization Combined With Sorafenib.
Front Oncol
; 10: 525461, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33392064
8.
Deep Learning Predicts Overall Survival of Patients With Unresectable Hepatocellular Carcinoma Treated by Transarterial Chemoembolization Plus Sorafenib.
Front Oncol
; 10: 593292, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33102242
Resultados
1 -
8
de 8
1
Próxima >
>>